Global Cancer Vaccine Market to Generate USD 13.4 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
March 23, 2023 09:00 ET
|
Next Move Strategy Consulting
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the global Cancer Vaccine Market generated USD 5.75 billion in 2022 and is projected to...
Icosavax to Participate in the Upcoming Healthcare Conferences
February 28, 2023 08:00 ET
|
Icosavax, Inc.
SEATTLE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Icosavax Granted FDA Fast Track Designation for IVX-A12
February 21, 2023 08:00 ET
|
Icosavax, Inc.
SEATTLE, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
BioMed X Launches New T Cell Immunology Discovery Platform
February 14, 2023 06:00 ET
|
BioMed X Institute (990552)
HEIDELBERG, Germany, Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioMed X announced today the launch of its new immunology discovery platform that will allow for the accurate and fast identification of target...
We The Patriots USA Brings Lawsuit Against Idaho Daycare Over Refusing Vaccine Exemptions
February 09, 2023 08:22 ET
|
We The Patriots USA, Inc.
MERIDIAN, Idaho, Feb. 09, 2023 (GLOBE NEWSWIRE) -- A lawsuit funded by the nonprofit organization We The Patriots USA was filed today in Ada County District Court by local counsel D. Colton Boyles,...
[Latest] Global Pneumococcal Vaccine Market Size/Share Worth USD 12 Billion by 2030 at a 5.34% CAGR: Growing cases of pneumonia to impact global market growth - Facts & Factors (Industrial Trends, Report, Forecast, Growth, Segmentation)
February 08, 2023 07:17 ET
|
Facts & Factors
SAN FRANCISCO, USA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Pneumococcal Vaccine Market Size, Share, Growth Analysis Report By Sector (Public...
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
February 01, 2023 07:20 ET
|
GreenLight Biosciences
The Rwanda FDA has given regulatory approval to GreenLight to start a Phase I/II clinical trial of its Covid-19 vaccine candidate in Rwanda. This phase I/II clinical trial is the first step in...
Global Cattle Healthcare Market to Surpass US$ 13,500.9 Million by 2030, Says Coherent Market Insights (CMI)
January 24, 2023 09:45 ET
|
CMI
Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Cattle Healthcare Market is estimated to be valued at US$ 8,313.5 million in 2022 and is expected to...
Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology
January 09, 2023 08:00 ET
|
Vaccinex, Inc.
ROCHESTER, N.Y., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative...
HilleVax Announces Executive Management Appointments and Promotions
January 09, 2023 07:00 ET
|
HilleVax, Inc.
BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...